CALABRO', Paolo
 Distribuzione geografica
Continente #
EU - Europa 24.628
AS - Asia 9.578
NA - Nord America 9.087
SA - Sud America 1.852
AF - Africa 149
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 45.317
Nazione #
RU - Federazione Russa 17.188
US - Stati Uniti d'America 8.930
SG - Singapore 3.743
IE - Irlanda 2.467
CN - Cina 2.181
HK - Hong Kong 1.683
BR - Brasile 1.582
GB - Regno Unito 930
IT - Italia 884
UA - Ucraina 879
DE - Germania 764
VN - Vietnam 572
KR - Corea 438
FR - Francia 406
IN - India 310
SE - Svezia 306
FI - Finlandia 269
GR - Grecia 219
TR - Turchia 209
AR - Argentina 119
AT - Austria 96
JP - Giappone 93
BD - Bangladesh 66
MX - Messico 65
CA - Canada 60
ID - Indonesia 58
BE - Belgio 49
ZA - Sudafrica 43
EC - Ecuador 42
IQ - Iraq 37
PK - Pakistan 37
NL - Olanda 34
PL - Polonia 31
CO - Colombia 28
EG - Egitto 28
MA - Marocco 25
KE - Kenya 21
VE - Venezuela 21
ES - Italia 20
UZ - Uzbekistan 20
LT - Lituania 18
CL - Cile 16
PE - Perù 14
PY - Paraguay 14
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
IL - Israele 13
EU - Europa 12
JO - Giordania 12
IR - Iran 11
NP - Nepal 10
SA - Arabia Saudita 10
TH - Thailandia 10
TN - Tunisia 10
CZ - Repubblica Ceca 8
RS - Serbia 8
CH - Svizzera 7
CR - Costa Rica 7
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
KZ - Kazakistan 6
OM - Oman 6
PA - Panama 5
RO - Romania 5
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
NG - Nigeria 4
NO - Norvegia 4
AM - Armenia 3
HN - Honduras 3
MY - Malesia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AN - Antille olandesi 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
Totale 45.292
Città #
Moscow 6.086
Dublin 2.451
Santa Clara 1.888
Hong Kong 1.679
Jacksonville 1.376
Singapore 1.297
Chandler 1.101
Hefei 505
Seoul 427
Princeton 362
Ashburn 294
Roxbury 276
Beijing 246
Medford 241
Bengaluru 225
The Dalles 213
Ho Chi Minh City 207
Boardman 199
New York 196
Naples 157
Wilmington 145
Bremen 138
Cambridge 132
Houston 127
Ann Arbor 124
Dallas 119
Hanoi 119
São Paulo 117
Nuremberg 106
Woodbridge 106
San Mateo 105
Des Moines 84
Nanjing 61
Los Angeles 59
Rio de Janeiro 56
Munich 55
Falkenstein 53
Mountain View 49
Düsseldorf 48
Brussels 45
Belo Horizonte 37
Norwalk 37
Guangzhou 35
Milan 35
Vienna 35
Curitiba 34
Da Nang 33
Caserta 32
Aversa 31
Brasília 30
Helsinki 28
Rome 28
Jinan 27
Brooklyn 25
Turku 25
Porto Alegre 24
Haiphong 23
Johannesburg 23
Shanghai 23
Campinas 22
Ercolano 22
Hyderabad 22
Lappeenranta 22
London 22
Tianjin 21
Columbus 20
Nanchang 20
Boston 19
Salvador 19
Changsha 18
Hangzhou 18
Mexico City 18
Nairobi 18
Napoli 18
Philadelphia 18
Shenyang 18
Tashkent 17
Amsterdam 16
Baghdad 16
Frankfurt am Main 16
Istanbul 16
San Francisco 16
San Giovanni In Fiore 16
Thái Bình 16
Dhaka 15
Guayaquil 15
Redwood City 15
Tokyo 15
Toronto 15
Zhengzhou 15
Cairo 14
Jakarta 14
Guarulhos 13
Quito 13
San Jose 13
Stockholm 13
Amman 12
Casablanca 12
Hải Dương 12
Kraków 12
Totale 22.521
Nome #
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. 215
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 193
Right ventricular hypertrabeculation associated with double-outlet left ventricle: exaggeration of a normal pattern or right ventricular cardiomyopathy? 174
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 167
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation 163
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 160
. Accuratezza predittiva dell'elettrocardiogramma nell'identificazione dell'ipertrofia ventricolare sinistra. 157
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience 156
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 155
Adipose tissue and vascular inflammation in coronary artery disease. 154
Activated coagulation factor VII promotes smooth muscle cell proliferation in vitro. 154
Advanced Heart Failure in Special Population—Pediatric Age 153
A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy 148
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 146
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 145
Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and 'narrow' QRS 144
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 144
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience. 143
Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. 143
A simple method for the isolation, cultivation, and characterization of endothelial cells from rabbit coronary circulation 142
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 142
Adherence to PCSK9 inhibitors in high cardiovascular risk patients in real-world setting: results from a single-center experience and comparison with statin therapy 142
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 141
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 141
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 141
Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study) 140
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery Surgery After Stenting 2 140
A new character on the scene of cardiorenal syndrome 139
Association between left atrial myocardial function and exercise capacity in patients with either idiophatic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study 139
Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease? 139
Natural history of left ventricular hypertrophy in infants of diabetic mothers 138
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition 137
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 137
Cardiotrophin-1 and TNF-alpha circulating levels at rest and during cardiopulmonary exercise test in athletes and healthy individuals 136
Childhood obesity: An overview of laboratory medicine, exercise and microbiome 136
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis 135
. Left atrial strain/strain rate analylisis in patients with dilated cardiomyopathy. Correlation with clinical, electrocardiographic and echocardiographic findings 134
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the emerging role of the Cardiomyopathy Team 133
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 133
[Device therapy in chronic heart failure: a case of hypertrophic cardiomyopathy treated with cardiac contractility modulation therapy] 132
.: Correlations between right ventricular myocardial function and cardiac performance during exercise in adult patients late after repair of tetralogy of Fallot 132
[The COMPASS study] 132
. L’analisi DMI del ventricolo destro a riposo predice la performance all’apice dello sforzo dei pazienti adulti operati per tetralogia di Fallot 130
. Ultrasonic myocardial tissue characterization in normal and abnormal right ventricle 130
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience 130
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 130
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia 130
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 129
. Plasma CT1 analysis in patients with hypertrophic cardiomyopathy. 129
Nuove prospettive nella terapia dello scompenso cardiaco: Farmacogenetica, Farmacogenomica e terapia cellulare. 128
Activated platelets stimulate tissue factor expression in smooth muscle cells 128
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation 128
Antiplatelet therapy for non-ST-Segment elevation myocardial infarction in complex "real" Clinical Scenarios: A Consensus Document of the "campania NSTEMI Study Group" 128
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 127
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A contemporary reappraisal 127
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 127
Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry) 126
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 125
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries 124
Obesità in età pediatrica ed ipertensione arteriosa 124
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 123
Impact of GEne Polymorphisms, Platelet REactivity and the SYNTAX Score on 1-Year Clinical Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The GEPRESS Study. 122
Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy 122
. Integrated backscatter analysis of functional and textural findings in young patients with different pathophysiological models of right ventricular overload 122
Inflammation and cardiovascular disease: from pathogenesis to therapeutic target 121
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment 121
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 120
Feasibility and usefulness of right ventricular ultrasonic tissue characterization with integrated backscatter in patients with unsuccessfully operatively "repaired" tetralogy of Fallot 120
Registrazione del potenziale di azione monofasico e del recupero ventricolare a seguito di variazioni acute del sovraccarico di volume: evidenza in vivo del feedback elettromeccanico 120
Effect of body mass index reduction on serum hepcidin levels and iron status in obese children 119
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 118
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 117
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 117
Hypertrophic cardiomyopathy in a girl with Cornelia de Lange syndrome due to mutation in SMC1A. 117
Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives 116
Global longitudinal speckle-tracking strain is predictive of left ventricular remodeling after coronary angioplasty in patients with recent non-st elevation myocardial infarction. 116
Induction of tissue factor in the arterial wall during recurrent thrombus formation 116
Nutcracker syndrome. 116
Cardiac involvement in systemic sclerosis: 'early diagnosis-early management' approach 116
Antithrombotic therapy in patients with atrial high-rate episodes (AHREs): Current evidence and open questions 115
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 115
Update of the position document of the Italian Society of Interventional Cardiology (SICI-GISE) on the minimum requirements for hospitals and operators performing procedures of a transcatheter implantation of aortic valve prostheses 115
[Evaluation and percutaneous treatment of severely calcified coronary lesions] 115
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 114
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 114
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective 113
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 113
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 113
The athlete’s heart and hypertrophic cardiomyopathy: two conditions which may be misdiagnosed and coexistent. Which parameters should be analysed to distinguish one disease from the other? 112
Left ventricular non compaction in children. 112
The left atrial appendage: from embryology to prevention of thromboembolism 112
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 112
Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease 111
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 111
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 110
Visceral adiposity and arterial stiffness: Echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives 110
Echocardiographic evaluation of left ventricular systolic function in the down syndrome 110
Hepcidin in Obese Children as a Potential Mediator of the Association between Obesity and Iron Deficiency. 110
Potential clinical perspectives of Doppler myocardial imaging and strain rate imaging during stress echocardiography 109
Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography. 109
Totale 13.089
Categoria #
all - tutte 160.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.871


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.154 0 0 0 0 0 14 308 190 30 244 285 83
2021/20222.391 130 13 26 82 785 27 36 148 86 184 147 727
2022/20234.257 452 145 58 348 401 307 10 206 2.136 32 78 84
2023/20242.109 144 59 76 161 680 223 86 74 12 57 155 382
2024/20257.551 26 74 35 213 1.164 1.071 1.092 614 956 1.186 644 476
2025/202624.508 1.110 1.499 1.630 1.544 2.338 16.387 0 0 0 0 0 0
Totale 46.265